I. Truxova, L. Kasikova, M. Hensler, P. Skapa, J. Laco, L. Pecen, L. Belicova, I. Praznovec, M.J. Halaska, T. Brtnicky, E. Salkova, L. Rob, R. Kodet, J. Goc, C. Sautes-Fridman, W.H. Fridman, A. Ryska, L.Galluzzi, R. Spisek, J. Fucikova
Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients.
J Immunother Cancer. 2018 Dec 4;6(1):139. doi: 10.1186/s40425-018-0446-3.T. Buchler, P. Vasek, R. Spisek, P. Skrobanek, V. Horejsi
Tumour devascularisation as a potential immunotherapeutic strategy.
Oncoimmunology. 2018 Oct 11;8(1):e1526614. doi: 10.1080/2162402X.2018.1526614. eCollection 2019.M. Smith, E. García-Martínez, M.R. Pitter, J. Fucikova, R. Spisek, L. Zitvogel, G. Kroemer, L. Galluzzi
Trial Watch: Toll-like receptor agonists in cancer immunotherapy.
Oncoimmunology. 2018 Oct 11;7(12):e1526250. doi: 10.1080/2162402X.2018.1526250. eCollection 2018.